Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […]

» Read more

Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function

The onset of the coronavirus disease 2019 (COVID-19) brought about intensive research on the biological characteristics of the pathogen responsible, […]

» Read more

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Extensive testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a primary mitigation measure in controlling […]

» Read more
1 2